Table 2.
Clinicopathologic Features of Small Cell and Large Cell Subtypes
| Small Cell (n=17, 39%) |
Large Cell (n=27, 61%) |
|
|---|---|---|
| Mean Age (range) |
57.5 (21–82) |
60.4 (29–79) |
| Male:Female | 0.9 | 1.9 |
| Tumor Location | ||
| Head | 12 | 15 |
| Body | 1 | 2 |
| Tail | 3 | 8 |
| Median Tumor Size (cm) (range) | 3.5 (2.3–18) | 4 (2–14.5) |
| Mitoses/10HPF*(range) | 51 (21–92) | 37 (21–83) |
| Ki67 Labeling Index (range) | 75% (50–98%) | 66% (40–95%) |
| T Stage | ||
| T1 | 0 | 1 |
| T2 | 1 | 1 |
| T3 | 12 | 20 |
| Only Lymph Node Metastasis at Presentation | 10 | 16 |
| Any Metastasis at Presentation | ||
| Present | 14 | 23 |
| Absent | 2 | 3 |
| Median Survival (Months) (95% CI) | 6 (5, 20) | 16 (11, 18) |
| 2-year DSS** | 24.2% ± 11.7% | 22.2% ± 8.7% |
| 5-year DSS** | 16.2% ± 10.2% | 16.6% ± 8.1% |
HPF High power field
DSS disease-specific survival (expressed as mean ± standard error)